Cancer Incidence Projections in the United States Between 2015 and 2050

PEER REVIEWED

Figure 1.
Distribution of estimated 2015 and projected 2050 average annual cancer cases (all sites combined), by age group, United States. Numbers may not sum to total because of rounding.

Distribution of estimated 2015 and projected 2050 average annual cancer cases (all sites combined), by age group, United States. Numbers may not sum to total because of rounding.

Age, y	2015 (n = 1,534,500)	2050 (n = 2,286,300)
	No. (%)
<50	201,500 (13)	249,500 (11)
50–64	490,700 (32)	590,700 (26)
65–74	425,000 (28)	579,500 (25)
75–84	293,200 (19)	545,400 (24)
≥85	124,000 (8)	321,100 (14)

Return to Article

 

Figure 2. Estimated (2015) cancer cases and projected additional cases (2050) by cancer site, United States. Numbers may not sum to total because of rounding. Abbreviation: NOS, not otherwise specified.

Estimated (2015) cancer cases and projected additional cases (2050) by cancer site, United States. Numbers may not sum to total because of rounding. Abbreviation: NOS, not otherwise specified.

Type of Cancer	2015, n	2050, n
Breast	238,800	123,900
Prostate	193,200	82,300
Lung and bronchus	135,100	67,900
Colon and rectum	178,100	23,600
Melanoma of the skin	76,700	48,000
Non-Hodgkin lymphoma	68,000	28,700
Urinary bladder	68,900	27,200
Kidney and renal pelvis	52,800	40,300
Corpus and uterus, NOS	54,000	38,100
Thyroid	45,200	38,900
Leukemia	47,700	32,800
Pancreas	34,500	30,900
Oral cavity and pharynx	39,700	23,900
Liver and intrahepatic bile duct	48,100	12,600
Stomach	26,700	20,300
Myeloma	23,900	22,200
Ovary	22,500	6,600
Brain and other nervous system	21,200	7,800
Esophagus	14,700	5,200
Cervix uteri	11,400	200
Larynx	9,700	500
Hodgkin lymphoma	8,200	-400
Other	115,400	185,500

Return to Article

Top

Error processing SSI file